The revolution re-visited : clinical and genetics research paradigms and the productivity paradox in drug discovery
Year of publication: |
October 2016
|
---|---|
Authors: | Gittelman, Michelle |
Published in: |
Research policy : policy, management and economic studies of science, technology and innovation. - Amsterdam [u.a.] : Elsevier, ISSN 0048-7333, ZDB-ID 121149-3. - Vol. 45.2016, 8, p. 1570-1585
|
Subject: | R&D productivity | Drug discovery | Basic and applied research | Science-technology linkages | Pharmaceuticals | Biotechnology | Biotechnologie | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Produktivität | Productivity | Pharmakologie | Pharmacology | Forschung | Research | Industrieforschung | Industrial research | Welt | World | Technischer Fortschritt | Technological change |
-
Accelerating vaccine innovation for emerging infectious diseases via parallel discovery
Barberio, Joseph, (2023)
-
Financing vaccines for global health security
Vu, Jonathan T., (2022)
-
Byrski, Dennis, (2021)
- More ...
-
Gittelman, Michelle, (2000)
-
Japanese multinationals in Europe and the United States : some comparisons and contrasts
Dunning, John H., (1991)
-
Patent citations as a measure of knowledge flows : the influence of examiner citations
Alcácer, Juan, (2006)
- More ...